You are viewing: UK Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The UK Long Read Sequencing Market was valued at $48 Million in 2024 and projected to reach to $212.7 Million by 2029, representing a compound annual growth rate of 34.7%. The UK long read sequencing market is positioned for exceptional growth through 2029, driven by increasing clinical validation and NHS adoption of genomic testing protocols.

UK Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 34.7%, significantly outpacing global trends.
  • The UK's advanced healthcare infrastructure, substantial investment in genomic research, and growing adoption of precision medicine are driving this accelerated market growth. In 2024, the UK market is characterized by increasing demand from academic institutions, NHS trusts, and private diagnostic laboratories seeking to enhance their sequencing capabilities.
  • By 2029, the UK is expected to consolidate its position as a leading European hub for long read sequencing technologies.
  • Key drivers include rising prevalence of genetic disorders, expanded clinical applications, and the UK's commitment to genomic medicine through initiatives like the National Genomics Service. The UK market landscape reflects strong institutional support and regulatory frameworks that facilitate innovation.
  • Between 2024 and 2029, the UK will likely see increased commercialization of long read platforms, expanded reimbursement pathways, and deeper integration of sequencing into routine clinical diagnostics..

Key Market Statistics

  • CAGR (2024-2029) 34.7% CAGR
  • Market Size, 2024 ~USD 48 Million
  • Forecast, 2029 ~USD 212.7 Million
  • Country UK

UK Long Read Sequencing Market Overview

Rapid Market Expansion :

The UK long read sequencing market is projected to grow from £48.0 million in 2024 to £212.7 million by 2029, representing a robust 34.7% CAGR that outpaces global growth rates of 32.8%.

Advanced Healthcare Infrastructure :

The UK's world-class NHS and established genomic research institutions provide a strong foundation for long read sequencing adoption, with significant government backing for precision medicine initiatives.

Genomic Research Investment :

Substantial UK investment in genomic research programmes, including the 100,000 Genomes Project legacy, continues to drive demand for advanced sequencing technologies and clinical applications.

Precision Medicine Adoption :

Growing integration of long read sequencing into UK clinical diagnostics and personalized treatment pathways is accelerating market penetration across oncology, rare diseases, and infectious disease sectors.

UK Long Read Sequencing Market Dynamics

  • Healthcare providers are investing heavily in long read technologies to improve diagnostic accuracy for complex genetic conditions and cancer genomics.
  • Regulatory support and funding from UK Research and Innovation (UKRI) are strengthening the competitive landscape.
  • The convergence of falling sequencing costs, improved bioinformatics infrastructure, and growing clinician awareness will accelerate market penetration across secondary and tertiary care settings.
  • By 2029, long read sequencing is expected to become a standard component of UK precision medicine programmes, with expanded applications in rare disease diagnosis and oncology..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The UK long read sequencing market is valued at £48.0 million in 2024 and is projected to grow to £212.7 million by 2029, representing a 34.7% CAGR.
    • The UK's advanced healthcare infrastructure and genomic research investments position it as a leading European market for long read sequencing adoption.
    • NHS integration and precision medicine initiatives in the UK are accelerating clinical adoption of long read sequencing technologies.
    • The UK market will see expanded reimbursement pathways and commercialization of long read platforms between 2024 and 2029.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    UK Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    UK: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE14.119.224.832.543.258.278.911135
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS4.66.38.210.814.519.626.837.935.8
    OTHER END USER2.33.13.84.86.2810.41429.6
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES6.48.711.214.719.526.235.449.834.8
    TOTAL27.537.34862.883.4111.9151.4212.734.7

    Target Audience

    • Sequencing Technology Providers : Equipment manufacturers and platform developers need UK market data to identify adoption barriers, NHS procurement pathways, and opportunities to expand long read sequencing installations across UK laboratories.
    • Diagnostic Service Companies : Clinical laboratories and genomic testing providers require market intelligence to assess UK demand for long read sequencing services, competitive positioning, and reimbursement models within NHS and private sectors.
    • Healthcare Investment Firms : Private equity and venture capital investors need UK-specific market forecasts and growth drivers to evaluate investment opportunities in genomic diagnostics and precision medicine companies.
    • NHS and Healthcare Commissioners : Hospital trusts and integrated care boards need evidence on long read sequencing clinical utility and cost-effectiveness to inform procurement decisions and genomic testing pathway development.
    • Pharmaceutical and Biotech Companies : Drug developers and biotech firms require UK market insights to understand precision medicine adoption, companion diagnostic opportunities, and patient stratification potential in UK clinical trials.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Access precise valuation data for the UK market (£48.0M in 2024) with detailed forecasts through 2029, enabling accurate budget allocation and investment planning for UK operations.
    • Competitive Landscape Intelligence : Understand UK-specific competitive dynamics, key players, and market positioning strategies tailored to the NHS environment and UK regulatory framework.
    • Growth Driver Analysis : Identify UK-specific growth catalysts including NHS adoption rates, genomic research funding, and precision medicine initiatives driving the 34.7% CAGR.
    • Clinical Adoption Insights : Gain detailed understanding of long read sequencing adoption across UK healthcare sectors, including secondary care, tertiary centres, and private diagnostics.
    • Strategic Market Entry : Develop evidence-based UK market entry strategies with segmentation by application, end-user type, and geographic opportunity within England, Scotland, Wales, and Northern Ireland.

    Frequently asked questions

    What is the current size of the UK long read sequencing market in 2024?

    The UK long read sequencing market is valued at £48.0 million in 2024, with strong growth anticipated through the forecast period.

    What is the projected market size for the UK long read sequencing market by 2029?

    The UK long read sequencing market is forecast to reach £212.7 million by 2029, representing a 34.7% compound annual growth rate.

    What factors are driving growth in the UK long read sequencing market?

    Key growth drivers in the UK include NHS adoption, precision medicine initiatives, rising genetic disorder prevalence, expanded clinical applications, and strong institutional research support.

    How does the UK long read sequencing market compare to global growth rates?

    The UK market is growing at 34.7% CAGR, outpacing the global average of 32.8%, reflecting the UK's leadership in genomic medicine adoption.

    Which sectors are driving demand for long read sequencing in the UK?

    Demand in the UK is driven by NHS trusts, academic research institutions, private diagnostic laboratories, and clinical genetics centers seeking enhanced sequencing capabilities.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status